WallStreetZenWallStreetZen

NASDAQ: APLS
Apellis Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for APLS

Based on 14 analysts offering 12 month price targets for Apellis Pharmaceuticals Inc.
Min Forecast
$29.00-53.77%
Avg Forecast
$66.29+5.67%
Max Forecast
$93.00+48.25%

Should I buy or sell APLS stock?

Based on 14 analysts offering ratings for Apellis Pharmaceuticals Inc.
Strong Buy
Strong Buy
8 analysts 57.14%
Buy
3 analysts 21.43%
Hold
3 analysts 21.43%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their APLS stock forecasts and price targets.

APLS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-12-05
lockedlocked$00.00+00.00%2023-11-09
lockedlocked$00.00+00.00%2023-11-02
lockedlocked$00.00+00.00%2023-11-02
lockedlocked$00.00+00.00%2023-11-01
Bank of America
Bottom 9%
9
HoldMaintains$46.00-26.67%2023-10-12
Citigroup
Top 18%
83
Strong BuyMaintains$70.00+11.59%2023-10-06
JP Morgan
Bottom 5%
5
Strong BuyUpgrades$81.00+29.12%2023-10-06
HC Wainwright & Co.
Top 20%
81
BuyReiterates$82.00+30.72%2023-09-26
Wells Fargo
Top 2%
99
Strong BuyUpgrades$64.00+2.02%2023-09-15Find out why

1 of 2

Forecast return on equity

Is APLS forecast to generate an efficient return?
Company
N/A
Industry
-0.69%
Market
30.34%

Forecast return on assets

Is APLS forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.29%

APLS revenue forecast

What is APLS's revenue in the next 3 years based on estimates from 8 analysts?
Avg 1 year Forecast
$371.7M+36.2%
Avg 2 year Forecast
$663.0M+142.98%
Avg 3 year Forecast
$1.1B+285.58%
APLS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

APLS revenue growth forecast

How is APLS forecast to perform vs Biotechnology companies and vs the US market?
Company
56%
Industry
34.65%
Market
7.68%
APLS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
APLS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

APLS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
APLS$62.73$66.29+5.67%Strong Buy
CERE$41.22$37.38-9.33%Hold
JAZZ$120.42$192.38+59.75%Buy
KRTX$205.48$262.80+27.90%Strong Buy
IMGN$29.21$26.48-9.35%Buy
View Top Biotech Stocks

Apellis Pharmaceuticals Stock Forecast FAQ

Is Apellis Pharmaceuticals Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 14 Wall Street analysts covering (NASDAQ: APLS) stock is to Strong Buy APLS stock.

Out of 14 analysts, 8 (57.14%) are recommending APLS as a Strong Buy, 3 (21.43%) are recommending APLS as a Buy, 3 (21.43%) are recommending APLS as a Hold, 0 (0%) are recommending APLS as a Sell, and 0 (0%) are recommending APLS as a Strong Sell.

If you're new to stock investing, here's how to buy Apellis Pharmaceuticals stock.

What is APLS's revenue growth forecast for 2023-2025?

(NASDAQ: APLS) Apellis Pharmaceuticals's forecast annual revenue growth rate of 56% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.65%, and it is also forecast to beat the US market's average forecast revenue growth rate of 7.68%.

Apellis Pharmaceuticals's revenue in 2023 is $272,877,000.On average, 8 Wall Street analysts forecast APLS's revenue for 2023 to be $44,040,623,059, with the lowest APLS revenue forecast at $39,910,781,476, and the highest APLS revenue forecast at $46,681,631,333. On average, 8 Wall Street analysts forecast APLS's revenue for 2024 to be $78,570,440,533, with the lowest APLS revenue forecast at $47,328,878,033, and the highest APLS revenue forecast at $103,029,895,680.

In 2025, APLS is forecast to generate $124,680,902,131 in revenue, with the lowest revenue forecast at $92,687,101,981 and the highest revenue forecast at $153,949,440,547.

What is APLS's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: APLS) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.29%.

What is APLS's Price Target?

According to 14 Wall Street analysts that have issued a 1 year APLS price target, the average APLS price target is $66.29, with the highest APLS stock price forecast at $93.00 and the lowest APLS stock price forecast at $29.00.

On average, Wall Street analysts predict that Apellis Pharmaceuticals's share price could reach $66.29 by Dec 5, 2024. The average Apellis Pharmaceuticals stock price prediction forecasts a potential upside of 5.67% from the current APLS share price of $62.73.

What is APLS's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: APLS) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.